JP6446044B2 - 結合分子の存在下で被検体の総量および／または総濃度を決定するための方法、ならびにそれに関係するキット、組成物および使用 - Google Patents

結合分子の存在下で被検体の総量および／または総濃度を決定するための方法、ならびにそれに関係するキット、組成物および使用 Download PDF

Info

Publication number
JP6446044B2
JP6446044B2 JP2016527237A JP2016527237A JP6446044B2 JP 6446044 B2 JP6446044 B2 JP 6446044B2 JP 2016527237 A JP2016527237 A JP 2016527237A JP 2016527237 A JP2016527237 A JP 2016527237A JP 6446044 B2 JP6446044 B2 JP 6446044B2
Authority
JP
Japan
Prior art keywords
molecule
analyte
binding
antibody
binding molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016527237A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016535266A (ja
JP2016535266A5 (https=
Inventor
シュレムル，ミハエル
レスラー，マルクス
ゲルク，ミハエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2016535266A publication Critical patent/JP2016535266A/ja
Publication of JP2016535266A5 publication Critical patent/JP2016535266A5/ja
Application granted granted Critical
Publication of JP6446044B2 publication Critical patent/JP6446044B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2016527237A 2013-11-05 2014-11-03 結合分子の存在下で被検体の総量および／または総濃度を決定するための方法、ならびにそれに関係するキット、組成物および使用 Active JP6446044B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13005218 2013-11-05
EP13005218.6 2013-11-05
EP14002015.7 2014-06-11
EP14002015 2014-06-11
PCT/EP2014/073523 WO2015067547A1 (en) 2013-11-05 2014-11-03 A method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto

Publications (3)

Publication Number Publication Date
JP2016535266A JP2016535266A (ja) 2016-11-10
JP2016535266A5 JP2016535266A5 (https=) 2017-11-16
JP6446044B2 true JP6446044B2 (ja) 2018-12-26

Family

ID=51845410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016527237A Active JP6446044B2 (ja) 2013-11-05 2014-11-03 結合分子の存在下で被検体の総量および／または総濃度を決定するための方法、ならびにそれに関係するキット、組成物および使用

Country Status (7)

Country Link
US (2) US10564151B2 (https=)
EP (1) EP3066469B1 (https=)
JP (1) JP6446044B2 (https=)
CN (1) CN105683755B (https=)
CA (1) CA2926306C (https=)
ES (1) ES2654906T3 (https=)
WO (1) WO2015067547A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180299436A1 (en) * 2017-01-20 2018-10-18 Shenzhen New Industries Biomedical Engineering Co., Ltd. A method, kit and system for preparing an antibody pair and the use of the kit
WO2024158727A2 (en) * 2023-01-24 2024-08-02 University Of Cincinnati Depletion-limited analyte sensing with non-equilibrium binding probes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
DE4214922C2 (de) 1992-05-06 1996-06-13 Brahms Diagnostica Gmbh Verfahren zur quantitativen Bestimmung des Anteils der freien Form eines Schilddrüsenhormon-Liganden in einer biologischen Flüssigkeit und Kit zur Durchführung eines solchen Verfahrens
US5312730A (en) 1992-05-27 1994-05-17 Ciba Corning Diagnostics Corp. Immune complex transfer with lypophilic bridge
JPH10513260A (ja) * 1995-01-31 1998-12-15 ノボ ノルディスク アクティーゼルスカブ 前臨床的に糖尿病を診断する方法
US6838250B2 (en) 2000-03-31 2005-01-04 Ortho-Clinical Diagnostics, Inc. Immunoassay for C-reactive protein
CA2535804A1 (en) * 2003-08-14 2005-03-03 Wyeth Anti-lewis y anti-idiotypic antibodies and uses thereof
MXPA06011824A (es) * 2004-04-16 2006-12-15 Genentech Inc Ensayo para anticuerpos.
EP1861708A2 (en) * 2005-03-08 2007-12-05 Tanox, Inc. Methods for determining the bivalency of protein and antibody therapeutics
US20090246795A1 (en) 2005-12-22 2009-10-01 Rohm Co., Ltd. Immunoassay device and method
EP1801594A1 (en) * 2005-12-23 2007-06-27 Koninklijke Philips Electronics N.V. Sensing device and method for determination of the amount of target molecule in an analyte
US20080127359A1 (en) * 2006-11-06 2008-05-29 Hermann Beck Method for producing anti-idiotypic antibodies
TWI434855B (zh) * 2006-11-21 2014-04-21 Hoffmann La Roche 結合物及其在免疫分析中作為參考標準之用途
MX2010002269A (es) 2007-08-28 2010-03-25 Abbott Biotech Ltd Composiciones y metodos que comprenden proteinas de union para adalimumab.
FR2980271B1 (fr) * 2011-09-16 2013-10-11 Cisbio Bioassays Procede de determination de la glycosylation d'un anticorps
CA2853917A1 (en) * 2011-12-19 2013-06-27 F. Hoffmann-La Roche Ag Method for the detection of free binding partner of a multispecific binder
JP2015507193A (ja) * 2012-02-01 2015-03-05 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 多重特異性結合物の結合パートナーを検出するための方法
MX346146B (es) * 2012-07-13 2017-03-09 Hoffmann La Roche Metodo para detectar un aglutinante multiespecifico.
PH12021552742A1 (en) * 2013-08-01 2022-05-23 Five Prime Therapeutics Inc Afucosylated anti-fgfr2iiib antibodies

Also Published As

Publication number Publication date
JP2016535266A (ja) 2016-11-10
HK1225799A1 (zh) 2017-09-15
EP3066469B1 (en) 2017-10-11
EP3066469A1 (en) 2016-09-14
CA2926306A1 (en) 2015-05-14
US20200141930A1 (en) 2020-05-07
US10564151B2 (en) 2020-02-18
ES2654906T8 (es) 2018-02-26
CN105683755A (zh) 2016-06-15
WO2015067547A1 (en) 2015-05-14
US12158466B2 (en) 2024-12-03
CN105683755B (zh) 2019-08-13
ES2654906T3 (es) 2018-02-15
CA2926306C (en) 2022-12-06
US20160252500A1 (en) 2016-09-01

Similar Documents

Publication Publication Date Title
TWI796328B (zh) Ｂ７-ｈ３抗體、其抗原結合片段及其醫藥用途
JP6437913B2 (ja) 複合体特異的抗体及び抗体断片並びにその使用
JP6602884B2 (ja) ビタミンｄの測定法
JP2022513694A (ja) 抗ｐｄ－ｌ１／抗４－１ｂｂ二重特異性抗体およびその使用
TW201323441A (zh) 抗ｔｎｆ之雙特異性免疫結合物
WO2014089209A2 (en) Blood-brain barrier (bbb) penetrating dual specific binding proteins
KR102661060B1 (ko) 항인간 IgG4 모노클로날 항체, 및 그 항체를 이용한 인간 IgG4 측정 시약
TW202434888A (zh) 用於偵測及測定包括生物流體在內之流體中之蛋白質結構及穩定性的方法
WO2026012501A1 (zh) 一种抗ngf单克隆抗体及其应用
US12158466B2 (en) Method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto
CN109336973B (zh) 抗转铁蛋白抗体及其用途
CN110343181B (zh) 针对凝血因子ix(fix)的单域抗体
TW202204406A (zh) 抗個體遺傳型抗體及使用其之方法
WO2024064600A2 (en) B-cell maturation antigen (bcma) anti-idiotypic antibodies
CA3232218A1 (en) Assays to quantitate drug and target concentrations
HK1225799B (zh) 陷阱分子和检测分子的用途及其相关试剂盒和组合物
WO2022078490A1 (zh) 抗erbb3抗体或其抗原结合片段及其医药用途
TWI869740B (zh) 一種體外檢測ｓＴＮＦＲ２蛋白濃度的方法及其檢測試劑和檢測試劑盒
US20250154242A1 (en) Anti-tnf-alpha antibodies and compositions
CN116744971A (zh) 一种抗erbb3受体的抗体或其抗原结合片段及其医药用途
HK40096312A (zh) 用於解析复杂、多步骤抗体相互作用的方法
IL300284A (en) Compounds and methods directed against human and murine INSL5

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171005

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171005

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180705

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181005

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20181102

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181130

R150 Certificate of patent or registration of utility model

Ref document number: 6446044

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250